Scleral lenses in the management of ocular surface disease

Muriel M. Schornack, Jeff Pyle, Sanjay V. Patel

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Purpose To describe the management of ocular surface disease with commercially available scleral lenses. Design Retrospective case series at a tertiary referral center. Participants A total of 212 patients (346 eyes) who were evaluated for scleral lens therapy for the management of ocular surface disease between June 1, 2006, and November 30, 2011. Methods Retrospective review of medical records and analysis of a survey mailed to all patients who completed the scleral lens fitting process to evaluate the long-term success of scleral lens therapy in the management of ocular surface disease. Main Outcome Measures Therapeutic outcome of scleral lens therapy, improvement in visual acuity with scleral lenses, indications for scleral lens wear, and efficiency of fitting process. Results Of the 212 subjects, 115 (188 eyes) successfully completed the scleral lens fitting process, and therapeutic goals (improved comfort, ocular surface protection, or resolution of keratopathy) were achieved in all but 2 of these subjects. Visual acuity improved with scleral lens wear, from 0.32±0.37 logarithm of the minimal angle of resolution (logMAR) (mean ± standard deviation; Snellen equivalent, 20/42) with habitual correction to 0.12±0.19 logMAR (Snellen equivalent, 20/26) with scleral lenses (P < 0.001). The most common indications for scleral lens therapy were undifferentiated ocular surface disease, exposure keratopathy, and neurotrophic keratopathy. Subjects had attempted an average of 3.2 (range, 0-8) other forms of intervention before scleral lens wear. Scleral lens fitting was completed in an average of 3 visits (range, 2-6), with an average of 1.4 lenses/eye (range, 1-4). Three patients experienced complications during scleral lens wear that resolved without loss of visual acuity, enabling resumption of scleral lens wear. Conclusions Commercially available scleral lenses can be successfully used in the management of moderate to severe ocular surface disease. The scleral lens fitting process can be completed efficiently for most eyes by using diagnostic trial lenses. In addition to protecting the ocular surface, scleral lenses improve visual acuity in patients whose surface disease has compromised vision.

Original languageEnglish (US)
Pages (from-to)1398-1405
Number of pages8
JournalOphthalmology
Volume121
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Eye Diseases
Lenses
Visual Acuity
Therapeutics
Crystalline Lens

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Scleral lenses in the management of ocular surface disease. / Schornack, Muriel M.; Pyle, Jeff; Patel, Sanjay V.

In: Ophthalmology, Vol. 121, No. 7, 2014, p. 1398-1405.

Research output: Contribution to journalArticle

Schornack, MM, Pyle, J & Patel, SV 2014, 'Scleral lenses in the management of ocular surface disease', Ophthalmology, vol. 121, no. 7, pp. 1398-1405. https://doi.org/10.1016/j.ophtha.2014.01.028
Schornack, Muriel M. ; Pyle, Jeff ; Patel, Sanjay V. / Scleral lenses in the management of ocular surface disease. In: Ophthalmology. 2014 ; Vol. 121, No. 7. pp. 1398-1405.
@article{efbefd8c5f9d4c16a2b090c6aa376ada,
title = "Scleral lenses in the management of ocular surface disease",
abstract = "Purpose To describe the management of ocular surface disease with commercially available scleral lenses. Design Retrospective case series at a tertiary referral center. Participants A total of 212 patients (346 eyes) who were evaluated for scleral lens therapy for the management of ocular surface disease between June 1, 2006, and November 30, 2011. Methods Retrospective review of medical records and analysis of a survey mailed to all patients who completed the scleral lens fitting process to evaluate the long-term success of scleral lens therapy in the management of ocular surface disease. Main Outcome Measures Therapeutic outcome of scleral lens therapy, improvement in visual acuity with scleral lenses, indications for scleral lens wear, and efficiency of fitting process. Results Of the 212 subjects, 115 (188 eyes) successfully completed the scleral lens fitting process, and therapeutic goals (improved comfort, ocular surface protection, or resolution of keratopathy) were achieved in all but 2 of these subjects. Visual acuity improved with scleral lens wear, from 0.32±0.37 logarithm of the minimal angle of resolution (logMAR) (mean ± standard deviation; Snellen equivalent, 20/42) with habitual correction to 0.12±0.19 logMAR (Snellen equivalent, 20/26) with scleral lenses (P < 0.001). The most common indications for scleral lens therapy were undifferentiated ocular surface disease, exposure keratopathy, and neurotrophic keratopathy. Subjects had attempted an average of 3.2 (range, 0-8) other forms of intervention before scleral lens wear. Scleral lens fitting was completed in an average of 3 visits (range, 2-6), with an average of 1.4 lenses/eye (range, 1-4). Three patients experienced complications during scleral lens wear that resolved without loss of visual acuity, enabling resumption of scleral lens wear. Conclusions Commercially available scleral lenses can be successfully used in the management of moderate to severe ocular surface disease. The scleral lens fitting process can be completed efficiently for most eyes by using diagnostic trial lenses. In addition to protecting the ocular surface, scleral lenses improve visual acuity in patients whose surface disease has compromised vision.",
author = "Schornack, {Muriel M.} and Jeff Pyle and Patel, {Sanjay V.}",
year = "2014",
doi = "10.1016/j.ophtha.2014.01.028",
language = "English (US)",
volume = "121",
pages = "1398--1405",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Scleral lenses in the management of ocular surface disease

AU - Schornack, Muriel M.

AU - Pyle, Jeff

AU - Patel, Sanjay V.

PY - 2014

Y1 - 2014

N2 - Purpose To describe the management of ocular surface disease with commercially available scleral lenses. Design Retrospective case series at a tertiary referral center. Participants A total of 212 patients (346 eyes) who were evaluated for scleral lens therapy for the management of ocular surface disease between June 1, 2006, and November 30, 2011. Methods Retrospective review of medical records and analysis of a survey mailed to all patients who completed the scleral lens fitting process to evaluate the long-term success of scleral lens therapy in the management of ocular surface disease. Main Outcome Measures Therapeutic outcome of scleral lens therapy, improvement in visual acuity with scleral lenses, indications for scleral lens wear, and efficiency of fitting process. Results Of the 212 subjects, 115 (188 eyes) successfully completed the scleral lens fitting process, and therapeutic goals (improved comfort, ocular surface protection, or resolution of keratopathy) were achieved in all but 2 of these subjects. Visual acuity improved with scleral lens wear, from 0.32±0.37 logarithm of the minimal angle of resolution (logMAR) (mean ± standard deviation; Snellen equivalent, 20/42) with habitual correction to 0.12±0.19 logMAR (Snellen equivalent, 20/26) with scleral lenses (P < 0.001). The most common indications for scleral lens therapy were undifferentiated ocular surface disease, exposure keratopathy, and neurotrophic keratopathy. Subjects had attempted an average of 3.2 (range, 0-8) other forms of intervention before scleral lens wear. Scleral lens fitting was completed in an average of 3 visits (range, 2-6), with an average of 1.4 lenses/eye (range, 1-4). Three patients experienced complications during scleral lens wear that resolved without loss of visual acuity, enabling resumption of scleral lens wear. Conclusions Commercially available scleral lenses can be successfully used in the management of moderate to severe ocular surface disease. The scleral lens fitting process can be completed efficiently for most eyes by using diagnostic trial lenses. In addition to protecting the ocular surface, scleral lenses improve visual acuity in patients whose surface disease has compromised vision.

AB - Purpose To describe the management of ocular surface disease with commercially available scleral lenses. Design Retrospective case series at a tertiary referral center. Participants A total of 212 patients (346 eyes) who were evaluated for scleral lens therapy for the management of ocular surface disease between June 1, 2006, and November 30, 2011. Methods Retrospective review of medical records and analysis of a survey mailed to all patients who completed the scleral lens fitting process to evaluate the long-term success of scleral lens therapy in the management of ocular surface disease. Main Outcome Measures Therapeutic outcome of scleral lens therapy, improvement in visual acuity with scleral lenses, indications for scleral lens wear, and efficiency of fitting process. Results Of the 212 subjects, 115 (188 eyes) successfully completed the scleral lens fitting process, and therapeutic goals (improved comfort, ocular surface protection, or resolution of keratopathy) were achieved in all but 2 of these subjects. Visual acuity improved with scleral lens wear, from 0.32±0.37 logarithm of the minimal angle of resolution (logMAR) (mean ± standard deviation; Snellen equivalent, 20/42) with habitual correction to 0.12±0.19 logMAR (Snellen equivalent, 20/26) with scleral lenses (P < 0.001). The most common indications for scleral lens therapy were undifferentiated ocular surface disease, exposure keratopathy, and neurotrophic keratopathy. Subjects had attempted an average of 3.2 (range, 0-8) other forms of intervention before scleral lens wear. Scleral lens fitting was completed in an average of 3 visits (range, 2-6), with an average of 1.4 lenses/eye (range, 1-4). Three patients experienced complications during scleral lens wear that resolved without loss of visual acuity, enabling resumption of scleral lens wear. Conclusions Commercially available scleral lenses can be successfully used in the management of moderate to severe ocular surface disease. The scleral lens fitting process can be completed efficiently for most eyes by using diagnostic trial lenses. In addition to protecting the ocular surface, scleral lenses improve visual acuity in patients whose surface disease has compromised vision.

UR - http://www.scopus.com/inward/record.url?scp=84903817940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903817940&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2014.01.028

DO - 10.1016/j.ophtha.2014.01.028

M3 - Article

C2 - 24630687

AN - SCOPUS:84903817940

VL - 121

SP - 1398

EP - 1405

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 7

ER -